The University of Chicago Header Logo

Connection

Yusuke Nakamura to Time Factors

This is a "connection" page, showing publications Yusuke Nakamura has written about Time Factors.
Connection Strength

0.288
  1. Cancer vaccines. Clin Adv Hematol Oncol. 2011 Oct; 9(10):778-9.
    View in: PubMed
    Score: 0.047
  2. Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells. Int J Oncol. 2009 Oct; 35(4):673-81.
    View in: PubMed
    Score: 0.041
  3. Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839. Int J Oncol. 2003 Jul; 23(1):29-39.
    View in: PubMed
    Score: 0.027
  4. Maturational sequence of neuroblastoma revealed by molecular analysis on cDNA microarrays. Int J Oncol. 2002 Oct; 21(4):803-7.
    View in: PubMed
    Score: 0.025
  5. Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy. Cancer Lett. 2002 Jun 06; 180(1):75-82.
    View in: PubMed
    Score: 0.025
  6. Genome-wide screening by cDNA microarray of genes associated with matrix mineralization by human mesenchymal stem cells in vitro. Biochem Biophys Res Commun. 2002 Jan 11; 290(1):381-90.
    View in: PubMed
    Score: 0.024
  7. Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study. Cancer Sci. 2017 Jan; 108(1):73-80.
    View in: PubMed
    Score: 0.017
  8. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget. 2012 Dec; 3(12):1629-40.
    View in: PubMed
    Score: 0.013
  9. Colorectal cancer metastasis to the thyroid. Osaka City Med J. 2012 Dec; 58(2):67-75.
    View in: PubMed
    Score: 0.013
  10. Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays. Pharmacogenet Genomics. 2010 Jul; 20(7):451-4.
    View in: PubMed
    Score: 0.011
  11. Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci. 2009 Aug; 100(8):1502-9.
    View in: PubMed
    Score: 0.010
  12. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology. 2009 Jul; 137(1):188-98, 198.e1-2.
    View in: PubMed
    Score: 0.010
  13. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet. 2004; 49(3):134-140.
    View in: PubMed
    Score: 0.007
  14. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem. 2004 Feb 20; 279(8):6840-6.
    View in: PubMed
    Score: 0.007
  15. Cystatin 10, a novel chondrocyte-specific protein, may promote the last steps of the chondrocyte differentiation pathway. J Biol Chem. 2003 Nov 28; 278(48):48259-66.
    View in: PubMed
    Score: 0.007
  16. Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia. 2002 May-Jun; 4(3):268-74.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.